NewsBenzingaTranscripción de la llamada de resultados del segundo trimestre de 2026 de Trevi Therapeutics Transcripción de la llamada de resultados del segundo trimestre de 2026 de Trevi Therapeutics Benzinga 2026.10.12 09:32 (GMT+0) Open on Benzinga Other news Why Is Snowflake Stock Surging Monday? 18 Globo Titles Heading To Netflix In Unprecedented Licensing Agreement ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment RBC Capital Maintains Outperform on Regions Financial, Lowers Price Target to $32 Wells Fargo Maintains Equal-Weight on Greif, Lowers Price Target to $88 Piper Sandler Maintains Overweight on GCM Grosvenor, Lowers Price Target to $14.5
